Telemetric analysis to detect febrile responses in mice following vaccination with a live-attenuated virus vaccine

Vaccine

Volumn 27, Issue 49, 2009, Pages 6814-6823

  Martin, Shannon S ^a   Bakken, Russell R ^b   Lind, Cathleen M ^b   Reed, Douglas S ^c   Price, Jessica L ^a   Koeller, Craig A ^b   Parker, Michael D ^b   Hart, Mary Kate ^a   Fine, Donald L ^a  

^a A CSC Company   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Mouse; Telemetry; Vaccine

Indexed keywords

LIVE VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; CIRCADIAN RHYTHM; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; FEVER; IMMUNE RESPONSE; INBRED STRAIN; MONITORING; MOUSE; NONHUMAN; OUTBRED STRAIN; PHYSICAL ACTIVITY; PREDICTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TELEMETRY; VACCINATION; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS;

ANIMALS; ANTIBODIES, VIRAL; BEHAVIOR, ANIMAL; BODY TEMPERATURE; BODY WEIGHT; DISEASE MODELS, ANIMAL; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; ENCEPHALOMYELITIS, VENEZUELAN EQUINE; FEMALE; FEVER; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; SENSITIVITY AND SPECIFICITY; TELEMETRY; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 70350566074     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.09.013     Document Type: Article

References (29)

1. Kinney R.M., Johnson B.J., Welch J.B., Tsuchiya K.R., and Trent D.W. The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83. Virology 170 1 (1989) 19-30
2. Davis N.L., Powell N., Greenwald G.F., et al. Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone. Virology 183 1 (1991) 20-31
3. Hart M.K., Caswell-Stephan K., Bakken R., et al. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate. Vaccine 18 26 (2000) 3067-3075
4. Hart M.K., Lind C., Bakken R., Robertson M., Tammariello R., and Ludwig G.V. Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice. Vaccine 20 3-4 (2002) 616-622
5. Ludwig G.V., Turell M.J., Vogel P., et al. Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice. Am J Trop Med Hyg 64 1-2 (2001) 49-55
6. Steele K.E., Davis K.J., Stephan K., Kell W., Vogel P., and Hart M.K. Comparative neurovirulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H/HeN and BALB/c mice. Vet Pathol 35 5 (1998) 386-397
7. Turell M.J., and Parker M.D. Protection of hamsters by Venezuelan equine encephalitis virus candidate vaccine V3526 against lethal challenge by mosquito bite and intraperitoneal injection. Am J Trop Med Hyg 78 2 (2008) 328-332
8. Fine D.L., Roberts B.A., Terpening S.J., Mott J., Vasconcelos D., and House R.V. Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates. Vaccine 26 27-28 (2008) 3497-3506
9. Pratt W.D., Davis N.L., Johnston R.E., and Smith J.F. Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models. Vaccine 21 25-26 (2003) 3854-3862
10. Reed D.S., Lind C.M., Lackemeyer M.G., Sullivan L.J., Pratt W.D., and Parker M.D. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus. Vaccine 23 24 (2005) 3139-3147
11. Fine D.L., Roberts B.A., Teehee M.L., et al. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses. Vaccine 25 10 (2007) 1868-1876
12. Holley P., Fine D.L., Terpening S.J., et al. Safety of an attenuated Venezuelan equine encephalititis virus (VEEV) vaccine in humans. 48th ICAAC/IDSA meeting. Washington, DC (2008)
13. Pratt W.D., Gibbs P., Pitt M.L., and Schmaljohn A.L. Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates. Vaccine 16 9-10 (1998) 1056-1064
14. Kramer K., Kinter L., Brockway B.P., Voss H.P., Remie R., and Van Zutphen B.L. The use of radiotelemetry in small laboratory animals: recent advances. Contemp Top Lab Anim Sci 40 1 (2001) 8-16
15. Kluger M.J., Conn C.A., Franklin B., Freter R., and Abrams G.D. Effect of gastrointestinal flora on body temperature of rats and mice. Am J Physiol 258 2 Pt 2 (1990) R552-R557
16. Clement J.G. Effect of a single dose of an acetylcholinesterase inhibitor on oxotremorine- and nicotine-induced hypothermia in mice. Pharmacol Biochem Behav 39 4 (1991) 929-934
17. Ishii K., Kuwahara M., Tsubone H., and Sugano S. The telemetric monitoring of heart rate, locomotor activity, and body temperature in mice and voles (Microtus arvalis) during ambient temperature changes. Lab Anim 30 1 (1996) 7-12
18. Clement J.G., Mills P., and Brockway B. Use of telemetry to record body temperature and activity in mice. J Pharmacol Methods 21 2 (1989) 129-140
19. Kozak W., Zheng H., Conn C.A., Soszynski D., van der Ploeg L.H., and Kluger M.J. Thermal and behavioral effects of lipopolysaccharide and influenza in interleukin-1 beta-deficient mice. Am J Physiol 269 5 Pt 2 (1995) R969-R977
20. Bjorklund O., Halldner-Henriksson L., Yang J., et al. Decreased behavioral activation following caffeine, amphetamine and darkness in A3 adenosine receptor knock-out mice. Physiol Behav 95 5 (2008) 668-676
21. Chen C.Y., Chow D., Chiamvimonvat N., et al. Short-term secondhand smoke exposure decreases heart rate variability and increases arrhythmia susceptibility in mice. Am J Physiol Heart Circ Physiol 295 2 (2008) H632-H639
22. Gilmore A.J., Billing R.L., and Einstein R. The effects on heart rate and temperature of mice and vas deferens responses to noradrenaline when their cage mates are subjected to daily restraint stress. Lab Anim 42 2 (2008) 140-148
23. Roghair R.D., Segar J.L., Volk K.A., et al. Vascular nitric oxide and superoxide anion contribute to sex-specific programmed cardiovascular physiology in mice. Am J Physiol Regul Integr Comp Physiol 296 3 (2009) R651-R662
24. Yang J.N., Chen J.F., and Fredholm B.B. Physiological roles of A1 and A2A adenosine receptors in regulating heart rate, body temperature, and locomotion as revealed using knockout mice and caffeine. Am J Physiol Heart Circ Physiol 296 4 (2009) H1141-H1149
25. Earley E., Peralta P.H., and Johnson K.M. A plaque neutralization method for arboviruses. Proc Soc Exp Biol Med 125 3 (1967) 741-747
26. Grieder F.B., Davis N.L., Aronson J.F., et al. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins. Virology 206 2 (1995) 994-1006
27. Hart M.K., Pratt W., Panelo F., Tammariello R., and Dertzbaugh M. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice. Vaccine 15 4 (1997) 363-369
28. FDA Guidance. Guidance for industry: animal models-essential elements to address efficacy under the animal rule (2009), U.S. Dept. Health and Human Services, Food and Drug Administration, Center for Biological Evaluation and Research
29. Boles J.W., Pitt M.L., LeClaire R.D., Gibbs P.H., Ulrich R.G., and Bavari S. Correlation of body temperature with protection against staphylococcal enterotoxin B exposure and use in determining vaccine dose-schedule. Vaccine 21 21-22 (2003) 2791-2796